Works matching IS 15608115 AND DT 2022 AND VI 30 AND IP 2
Results: 14
Availability and affordability of cardiovascular medicines in a major city of Afghanistan in 2020.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2022, v. 30, n. 2, p. 343, doi. 10.1007/s40199-022-00454-8
- By:
- Publication type:
- Article
Mesoporous silica coated SPIONs containing curcumin and silymarin intended for breast cancer therapy.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2022, v. 30, n. 2, p. 331, doi. 10.1007/s40199-022-00453-9
- By:
- Publication type:
- Article
Adverse drug reactions of Rituximab in patients suffering from autoimmune neurological diseases.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2022, v. 30, n. 2, p. 323, doi. 10.1007/s40199-022-00452-w
- By:
- Publication type:
- Article
Effect of vitamins C and E on cancer survival; a systematic review.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2022, v. 30, n. 2, p. 427, doi. 10.1007/s40199-022-00451-x
- By:
- Publication type:
- Article
A review on the synthesis of bio-based surfactants using green chemistry principles.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2022, v. 30, n. 2, p. 407, doi. 10.1007/s40199-022-00450-y
- By:
- Publication type:
- Article
Pharmacokinetic study of high-dose oral rifampicin in critically Ill patients with multidrug-resistant Acinetobacter baumannii infection.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2022, v. 30, n. 2, p. 311, doi. 10.1007/s40199-022-00449-5
- By:
- Publication type:
- Article
Dapsone improves the vincristine-induced neuropathic nociception by modulating neuroinflammation and oxidative stress.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2022, v. 30, n. 2, p. 303, doi. 10.1007/s40199-022-00448-6
- By:
- Publication type:
- Article
Novel biodegradable molecularly imprinted polymer nanoparticles for drug delivery of methotrexate anti-cancer; synthesis, characterization and cellular studies.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2022, v. 30, n. 2, p. 289, doi. 10.1007/s40199-022-00447-7
- By:
- Publication type:
- Article
A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2022, v. 30, n. 2, p. 379, doi. 10.1007/s40199-022-00446-8
- By:
- Publication type:
- Article
Alpinumisoflavone against cancer pro-angiogenic targets: In silico, In vitro, and In ovo evaluation.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2022, v. 30, n. 2, p. 273, doi. 10.1007/s40199-022-00445-9
- By:
- Publication type:
- Article
Efficacy and safety of ibrutinib in mantle cell lymphoma: A systematic review and meta-analysis.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2022, v. 30, n. 2, p. 367, doi. 10.1007/s40199-022-00444-w
- By:
- Publication type:
- Article
Protective and therapeutic effects of Scutellaria baicalensis and its main active ingredients baicalin and baicalein against natural toxicities and physical hazards: a review of mechanisms.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2022, v. 30, n. 2, p. 351, doi. 10.1007/s40199-022-00443-x
- By:
- Publication type:
- Article
Safety assessment of the pharmacological excipient, diethylene glycol monoethyl ether (DEGEE), using in vitro and in vivo systems.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Bioassay-Guided extraction of andrographis paniculata for intervention of in-vitro prostate cancer progression in metabolic syndrome environment.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2022, v. 30, n. 2, p. 253, doi. 10.1007/s40199-021-00414-8
- By:
- Publication type:
- Article